home All News open_in_new Full Article

Llegan a España nuevos tratamientos contra el cáncer de esófago y gástrico, financiados por Sanidad

A partir de este martes, 1 de abril, se incorporan en España dos nuevas indicaciones de Tevimbra (tislelizumab) a la cartera del Sistema Nacional de Salud (SNS) como tratamiento "primera línea" del adenocarcinoma gástrico o de la unión gastroesofágica y contra el carcinoma de células escamosas de esófago en combinación con quimioterapia basada en platino.


today 8 d. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events


ID: 1717526255
Add Watch Country

arrow_drop_down